New Jersey Gov. Phil Murphy is speaking Wednesday afternoon for the first time since the state stopped administering doses of the Johnson & Johnson COVID vaccine.
Murphy is speaking live at 1 p.m.
Murphy on Wednesday said the state’s goal of getting 4.7 million people in New Jersey fully vaccinated by the end of June remains attainable, despite the J&J pause.
The first-term Democrat also noted that the state will still open vaccine eligibility to everyone 16 and older on Monday as planned.
New Jersey will follow federal guidance and put Johnson & Johnson vaccines on hold, the state’s top health official said.
The Centers for Disease Control and Prevention and the Food and Drug Administration said Tuesday they were investigating unusual clots that occurred 6 to 13 days after vaccination. The clots occurred in veins that drain blood from the brain and occurred together with low platelets. All six cases were in women between the ages of 18 and 48; there was one death, and all cases remained under investigation.
More than 6.8 million doses of the J&J vaccine have been administered in the U.S., the vast majority with no or mild side effects.
As of Wednesday, New Jersey had received no reports of blood clotting issues with J&J vaccines administered in the state, Persichilli said.
The pause in New Jersey comes just as the supply of J&J vaccines ebbs from more than 130,000 last week to 15,000 this week. Next week just 5,000 doses of the single-shot vaccine are expected, Persichilli said.
Along with the New Jersey sites, federally run mass vaccination sites have paused the use of the J&J shot.
The other two authorized vaccines, from Moderna and Pfizer, make up the vast share of COVID-19 shots administered in the U.S. and are not affected by the pause.
This story is developing and will be updated.